Indegene Share Price Today | Stock Price & Indegene Share Screener
As of October 5, 2026, the live Indegene share price (NSE: INDGN) is ₹598.45 on NSE and ₹598.35 on BSE, up 0.83% from the previous close, with shares trading between ₹588.00 and ₹605.50 in today's trading session, and a 52-week range of ₹423.50–₹613.30. Check Indegene 52-week for the annual price range and momentum. Use the Indegene stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Indegene opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹1,092 and net income of ₹116, with EBITDA of ₹203, an operating margin of 16.0% and a profit margin of 10.6%.
Indegene Share Price Chart
Track the current stock price of Indegene with an interactive chart. Analyse INDGN share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Indegene stock quote in one place.
The quote of ₹598.45 sits between the 52-week low of ₹423.50 and the 52-week high of ₹613.30, and the latest session moved 0.83% from the previous close.
Indegene Company Profile - Fundamental Screener
Screen Indegene company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for INDGN shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Healthcare Technology industry, with Manish Gupta listed as chairperson or CEO, and it trades under ISIN INE065X01017.
Business Overview
Indegene Limited is a global provider of digital-led commercialization services for the life sciences industry. The company offers solutions in analytics, technology, and commercial, medical, regulatory, and safety services to biopharmaceutical, emerging biotech, and medical devices companies. Indegene operates through four main segments: Enterprise Commercial Solutions, Omnichannel Activation, Enterprise Medical...more
Company Details
Classification
Identifiers and Leadership
Indegene Balance Sheet Screener
Screen INDGN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹4,620, up from ₹3,326 in 2025.
Latest statistics put total assets at ₹4,620 and shareholder funds at ₹3,139, with a leverage ratio of 0.04.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
Assets |
||||||||
| Total Assets | 4,620 | 3,326 | 2,546 | 2,204 | 1,354 | 596 | 600 | 329 |
| Current Assets | 2,618 | 2,530 | 1,791 | 1,449 | 1,130 | 459 | 418 | 185 |
| Fixed Assets | 1,812 | 678 | 646 | 664 | 138 | 86 | 119 | 104 |
Liabilities |
||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 395 | 146 | 506 | 651 | 149 | 64 | 369 | 18 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||
| Total Equity | 3,139 | 2,616 | 1,429 | 1,064 | 764 | 333 | -16 | 152 |
| Share Capital | 48 | 48 | 44 | 44 | 0 | 0 | 0 | 79 |
| Reserves & Surplus | 3,090 | 2,567 | 1,385 | 1,020 | 764 | 324 | -105 | 73 |
Indegene Income Statement Screener - Profit & Revenue Analysis
Screen Indegene income statement and profit fundamentals. Analyze INDGN quarterly results. Indegene reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Jun, revenue was ₹1,092 and net profit was ₹116, equal to earnings per unit of ₹4.84, at an operating margin of 16%.
In that period expenses were ₹889, interest cost ₹6 and tax ₹37. The next period listed, 2026-Mar, shows revenue of ₹1,014 and net profit of ₹80.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 1,092 | 1,014 | 962 | 824 | 783 | 781 | 758 | 708 | 699 | 699 | 687 | 647 | 636 | 645 | 540 |
| Expenses | 889 | 860 | 783 | 664 | 606 | 608 | 589 | 561 | 548 | 534 | 525 | 515 | 511 | 535 | 413 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 203 | 154 | 179 | 160 | 177 | 173 | 170 | 148 | 151 | 164 | 162 | 133 | 125 | 111 | 127 |
| Operating Profit % | 16.00% | 14.00% | 17.00% | 17.00% | 20.00% | 20.00% | 18.00% | 18.00% | 19.00% | 21.00% | 22.00% | 19.00% | 16.00% | 15.00% | 21.00% |
| Depreciation | 44 | 42 | 40 | 23 | 22 | 21 | 20 | 19 | 20 | 19 | 18 | 20 | 20 | 20 | 10 |
| Interest | 6 | 7 | 5 | 4 | 4 | 3 | 3 | 4 | 12 | 12 | 12 | 12 | 13 | 12 | 2 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 153 | 105 | 135 | 133 | 152 | 149 | 146 | 124 | 120 | 134 | 132 | 101 | 93 | 79 | 115 |
| Tax | 37 | 25 | 32 | 31 | 36 | 32 | 37 | 32 | 32 | 39 | 34 | 26 | 24 | 30 | 29 |
| Net Profit | 116 | 80 | 103 | 102 | 116 | 118 | 110 | 92 | 88 | 95 | 99 | 75 | 68 | 49 | 86 |
| EPS | 4.84 | 3.32 | 4.29 | 4.26 | 4.86 | 4.91 | 4.59 | 3.84 | 3.79 | 4.27 | 4.45 | 3.38 | 3.09 | 2.20 | 3.88 |
Indegene Cash Flow Screener - Liquidity Fundamentals
Screen INDGN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹651, and net cash flow was an inflow of ₹60.
Over the same period, investing activities used ₹508 and financing activities used ₹83.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||
| Operating Activities | 651 | 442 | 508 | 130 | 297 | 172 | 22 | 65 |
| Investing Activities | -508 | -677 | -327 | -896 | -158 | -81 | -16 | -18 |
Financing and Net Cash | ||||||||
| Financing Activities | -83 | 288 | -66 | 333 | 234 | -132 | 136 | -21 |
| Net Cash Flow | 60 | 52 | 115 | -433 | 373 | -41 | 143 | 25 |
Indegene Shareholding Pattern Screener
See Indegene shareholding pattern with promoter, FII, and DII holdings. Check Indegene promoter holding and ownership changes for INDGN on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 0.00%, foreign institutions 10.27%, domestic institutions 8.30% and the public 12.57%, spread across 142,119 shareholders.
The shareholder count was 142,119 in 2026-Mar, compared with 138,533 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Apr |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Institutional Investors | ||||||||
| FII Holding | 10.27% | 9.91% | 5.24% | 10.05% | 11.30% | 11.48% | 3.56% | 0.00% |
| DII Holding | 8.30% | 8.74% | 4.96% | 7.20% | 6.96% | 8.07% | 5.33% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 12.57% | 12.49% | 11.34% | 13.51% | 13.28% | 12.45% | 11.38% | 0.00% |
| Other Holding | 68.87% | 68.86% | 78.45% | 69.24% | 68.46% | 68.00% | 79.73% | 100.00% |
| Shareholder Count | 142,119 | 138,533 | 144,708 | 151,997 | 151,809 | 147,182 | 443,785 | 82 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Indegene. Indegene dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹2.25 per unit for 2026-March, a yield of 0.37%, compared with ₹2.00 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹2.25, ₹2.00 and ₹0.00 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹2.25 | 0.37% |
| 2025-March | ₹2.00 | 0.46% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Indegene Stock Index Membership - Nifty & Sensex
See which indices include Indegene stock. Check INDGN index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
The company is listed in 11 indices, including BSE 1000.
Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX BSEIPO, BSE INDEX SMLCAP.
Complete Index List
Indegene Market Events Screener - Corporate Actions
Get Indegene corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Indegene stock events that may affect INDGN share price, along with derivatives, futures and options activity and sector gainers.
14 corporate actions are listed, the most recent entry being Annual General Meeting dated August 13, 2026, with a record date of August 13, 2026.
It is followed by Dividend dated July 31, 2026 and Quarterly Result Announcement dated July 30, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-13 | 2026-08-13 | Annual General Meeting | NA | 11.47% |
| 2026-07-31 | 2026-07-31 | Dividend | ₹ 2.25 /share | 2.95% |
| 2026-07-30 | 2026-07-30 | Quarterly Result Announcement | NA | 5.58% |
| 2026-04-29 | 2026-04-29 | Quarterly Result Announcement | NA | 3.54% |
| 2026-01-29 | 2026-01-29 | Quarterly Result Announcement | NA | -1.13% |
| 2025-10-30 | 2025-10-30 | Quarterly Result Announcement | NA | -1.67% |
| 2025-07-31 | 2025-07-31 | Quarterly Result Announcement | NA | -2.22% |
| 2025-06-26 | 2025-06-26 | Annual General Meeting | NA | -4.70% |
| 2025-06-13 | 2025-06-13 | Dividend | ₹ 2.00 /share | 5.49% |
| 2025-04-28 | 2025-04-28 | Quarterly Result Announcement | NA | -0.50% |
| 2025-01-30 | 2025-01-30 | Quarterly Result Announcement | NA | -6.18% |
| 2024-10-28 | 2024-10-28 | Quarterly Result Announcement | NA | 3.40% |
| 2024-09-06 | 2024-09-06 | Annual General Meeting | NA | 9.73% |
| 2022-11-17 | 2022-11-17 | Change Of Name | NA | - |
Indegene Competitors Screener - Peer Stocks Comparison
Screen INDGN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 9 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Syngene International | 14,823 | 68.69 | 3,809 | 2.56% | 317 | 34.28 |
| Indegene | 14,581 | 36.84 | 3,583 | 21.58% | 401 | 60.33 |
| Suven Life Sciences | 9,176 | -25.81 | 21 | 19.32% | -276 | 40.10 |
| Vimta Labs | 2,642 | 35.09 | 322 | 0.22% | 41 | 40.61 |
| Bilcare | 237 | -37.75 | 764 | -5.33% | -17 | 57.24 |
| TAKE | 207 | 16.89 | 61 | 497.06% | 4 | 32.52 |
| Jeevan Scientific Technology | 163 | 30.25 | 62 | 29.56% | 2 | 57.03 |
| Adeshwar Meditex | 24 | 33.09 | 56 | -33.21% | 1 | 21.12 |
| Vanta Bioscience | 15 | 136.87 | 2 | -13.33% | 0 | 49.20 |
Indegene Company Announcements - News & Reports Screener
Screen INDGN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 5, 2026.
The next most recent announcements are dated September 30, 2026 and September 10, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-05 | Closure of Trading Window | - |
| 2026-09-30 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-09-10 | Announcement under Regulation 30 (LODR)-Restructuring | - |
| 2026-09-08 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-31 | Announcement Under Regulation 30 (LODR) - Update On Material Litigation | - |
| 2026-08-19 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-19 | Announcement Under Regulation 30 (LODR) - Update On Material Litigation | - |
| 2026-08-17 | Transcript Of The 28Th Annual General Meeting Held On August 13 2026 | - |
| 2026-08-17 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-08-17 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-13 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-08-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-10 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-10 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-06 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-08-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-31 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-07-30 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹598.45, within a 52-week range of ₹423.50 to ₹613.30. The P/E ratio is 36.84 and the P/B ratio is 4.71, with earnings per unit of ₹16.72. Market capitalisation stands at ₹14,581.35 Cr and the dividend yield is 0.37%. The company operates in the Healthcare sector, in the Healthcare Technology industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 8 balance sheet periods, 15 income statement periods, 8 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.